“Real Voices”
Representative Director and CEO, Hmcomm Inc.
Establish new business field to substitute people’s hearing
—Create an environment that nurtures engineers who can cross swords on the global stage with their technology
In Japan, software development has been carried out as contract-based development, in which software is developed upon receiving an order from a corporate customer. This business model can be termed as similar to the general contractor in the civil engineering and construction industry.
On the other hand, we have the U.S. Silicon Valley style, which is the mainstream today. Companies raise funds on their own to create what they want by developing the technology and putting together a product, and seek the market’s opinion, at their own responsibility. Global IT companies such as Apple, Microsoft, Google, and Facebook began this way, grew, and became giants. They won the appreciation of the market and the world.
Which of these environments, the severe global market or a market protected in a sense by contracts, is more suitable for nurturing engineers with high skill levels? The answer is obvious.
Just like a global IT company from the U.S. does, I wanted to take risks by ourselves and play with our technology and achievements. I wanted to create an environment that nurtures super programmers and engineers who won’t lose to engineers at global IT companies. I was more than certain that Japan will definitely need such human resources in the future. This may sound too smart but it is true that this occupies a significant portion of my motivation for becoming independent and starting a company.
—Idea of commercializing Speech to Text of call centers
After coming back to Japan, I was checking out many things about voice recognition and learned about AIST’s technology transfer venture system. I applied to it, went through selection and was accepted as an AIST venture. This enabled me to use the excellent voice recognition technology owned by AIST. AIST introduced me to MUCAP in 2014, when we made a fresh start as an AIST venture.
When I met Mr. Nuibe, who is in charge at MUCAP, for the first time, I was not fully ready and did not have a proper business plan. Still, I needed funds. So, I tried to enthusiastically tell my story, but I believe I must have been going round in circles at times.
—Multifarious support including introduction of venders and investors
MUCAP, as a member of the Mitsubishi UFJ Financial Group, has relationships with a very wide range of companies, and I believe that is the backbone of the high potential we have as a VC. Incidentally, Mr. Nuibe is serving as an outside director of our company.
—Aiming for global expansion of the business that substitutes people’s hearing
We have also developed an AI operator which can respond naturally without human assistance, by combining voice recognition, voice synthesis, and natural language processing. This solution, named Terry, has been adopted by a major mail order company and a major electronics retail store and has been demonstrating its effectiveness in addressing operator shortage at times when number of calls increase sharply. Further, we are also taking on the challenge in the business of anomaly sound detection from voice feature. For example, this is being applied in various fields such as in detecting illness from the squeals of pigs in the animal husbandry field and detecting faults in the equipment and facilities field. We will polish the product further and hope to expand globally as a SaaS model.
While there are quite a few vision-related venture businesses, there are hardly any involved in substituting hearing even if you look globally and it can be called a blue ocean field. We intend to steadily and firmly push forward for the next leap.
Company
Hmcomm Inc.
Primary business activities
Company History
| 2012 | July | H&M Communication Corporation founded (Yokohama) |
|---|---|---|
| 2014 | June | Company name changed to Hmcomm Inc. |
| August | Tokyo Branch opened AIST technology transfer venture certification. |
|
| 2016 | December | Raised funds through a private placement of new shares (Series A). |
| 2017 | March | Head office relocated to Toranomon, Minato-ku, Tokyo. |
| 2018 | June | Raised funds through a private placement of new shares (Series B). |
| 2019 | December | Raised funds through a private placement of new shares (Series C). |
-
Transforming the future of cancer treatment through drug development
Hiroshi Miyake, Ph.D.
CEO, Chordia Therapeutics Inc. -
Bringing a breath of fresh air to senior high school graduate recruitment
Mitsuhide Sasaki
President, JINJIB Co., Ltd. -
Solving the space debris problem and achieving sustainability in space and on earth
Mitsunobu Okada, Founder and CEO Nobuhiro Matsuyama, Chief Financial Officer
Astroscale Holdings Inc. -
Giving elderly people and their caregiving families more reason to smile
Masashi Enami
President, Emimen Co., Ltd. -
Developing revolutionary drugs for diseases without effective treatment options
Takuro Wakabayashi
Chief Executive Officer, TMS Co., Ltd. -
All motivation stems from an attitude to find something interesting
Noriyuki Suzuki
President, Asterisk Inc. -
Captivating the world with manga, anime, and events
Takuro Ando
Founder & CEO, TORICO Co., Ltd. -
Keep innovating the vision of the contact center support operation
Tomohiro Ishii
President & CEO, Mobilus Corporation -
Turn customer voices into the growth engine of the company and business
Yusuke Yokoji
Representative Director, G-NEXT Inc. -
Aiming to Create a Cashless Society
Kentaro Sugiyama, President and CEO
Akira Takano, Executive Chairman
GMO Financial Gate, Inc. -
Aiming to provide platform services for store operations
Hiroshi Yamamoto
Representative Director, Smaregi, Inc. -
Desire to offer drugs that make it possible to be reborn for patients suffering from rare genetic diseases and their families as early as possible
Koji Fuji
CEO and COO, Reborna Biosciences, Inc. -
Establish new business field to substitute people’s hearing
Koji Mitsumoto
Representative Director and CEO, Hmcomm Inc. -
Aims to develop cancer drugs that you can recommend to a cancer patient in your family with confidence
Kiyoshi Eshima, Ph.D.
President, Delta-Fly Pharma -
Our mission is to create Japanese cybersecurity solutions for the global market
Yuji Ukai
President, FFRI Inc.